Canopy Growth adopts advance notice by-law for director nominations
Canopy Growth Corporation established a formal advance notice by-law governing shareholder nominations for board directors. The procedural governance change aims to standardize nom…
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Canopy Growth Corporation established a formal advance notice by-law governing shareholder nominations for board directors. The procedural governance change aims to standardize nom…
Borealis Foods received a NASDAQ notice on May 21, 2026 for failing to timely file its Q1 2026 10-Q report, supplementing a prior notice regarding its delayed 2025 10-K. The compan…
Bloom Energy's board and shareholders approved a second amendment to the restated certificate of incorporation on February 20 and May 21, 2026, respectively. The amendment renames …
MineralRite Corporation amended periodic SEC filings to reclassify its December 2024 Peeples and California Precious Metals acquisitions from business combinations to asset acquisi…
BridgeBio announced FDA acceptance of its New Drug Application for BBP-418 to treat LGMD2I/R9, a rare genetic muscular dystrophy, with a Priority Review designation and potential N…
Geron Corporation's Board amended its 2018 Equity Incentive Plan, most recently approved by stockholders on May 21, 2025, consolidating prior equity plans and managing share reserv…
F&M Bank Corp's board approved amendments to its 2020 Stock Incentive Plan that add a formal definition of Retirement, grant the Committee discretion to accelerate vesting upon Ret…
EFCAR LLC, the depositor for Exeter Select Automobile Receivables Trust 2026-1, engaged Morgan, Lewis & Bockius LLP as counsel for its Form SF-3 registration statement filing. Lega…
Progyny amended its certificate of incorporation to change director removal procedures and bylaw adoption requirements, now requiring majority stockholder votes. The company also a…
Flag Ship Acquisition Corp received a second notification from Nasdaq on May 21, 2026 for failing to timely file its Form 10-Q quarterly report, in addition to a previous notice re…
Warner Bros. Discovery, Inc. executed a supplemental indenture dated May 26, 2026, relating to multiple series of senior notes with maturities ranging from 2028 to 2049. This admin…
Jaguar Health received notice on May 26, 2026 that it has regained compliance with Nasdaq Listing Rule 5550(a)(2), allowing its securities to remain listed and traded on Nasdaq. Th…
MetaVia presented Phase 1 results for DA-1726 showing up to 9.1% mean body weight reduction at 48 mg dose with favorable safety and early liver improvements at EASL 2026. The dual …
Traws Pharma announced development of a novel dual-mechanism combination antiviral therapy designed to treat Hantavirus, Ebola, and Lassa virus infections, with plans to engage CDC…
bioAffinity Technologies announced notification of patent allowance from Mexico's Institute of Industrial Property for methods using flow cytometry and antibodies to detect lung ca…
Turn Therapeutics announced publication of a peer-reviewed study in the Journal of Dermatological Treatment demonstrating GX-03's efficacy in an IL-36-associated inflammatory derma…
Precision BioSciences announced late-breaking clinical data from the ELIMINATE-B study demonstrating that PBGENE-HBV directly eliminated cccDNA with a 10-fold reduction in viral tr…
Tonix announced publication of Phase 1 clinical data for TNX-1500 in the Journal of Clinical Immunology, showing the drug was well-tolerated with favorable safety profile. A Phase …
Apogee announced positive 16-week Part B induction dose optimization results from its Phase 2 APEX trial of zumilokibart, with 65.9% of mid-dose patients achieving EASI-75 endpoint…
Lumen Technologies filed amended and restated articles of incorporation detailing authorized capital structure of 2.2 billion common shares and 2 million preferred shares. The fili…